(Q38028844)

27 August 2017

title

Prevention and treatment of type 1 diabetes mellitus by the manipulation of invariant natural killer T cells (English)

1 reference

27 August 2017

0 references

Jan Novak

1

1 reference

27 August 2017

Lucie Novakova

series ordinal

2

1 reference

27 August 2017

publication date

24 July 2012

1 reference

Clinical and Experimental Medicine

27 August 2017

published in

1 reference

27 August 2017

volume

13

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

229-237

1 reference

https://scigraph.springernature.com/pub.10.1007/s10238-012-0199-0

27 August 2017

exact match

0 references

cites work

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Prediction and pathogenesis in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Etiology of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Diabetogenic T lymphocytes in human Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Type 1 diabetes: etiology, immunology, and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

T regulatory cells in autoimmune diabetes: past challenges, future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Regulation of type 1 diabetes by NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

NKT cells: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

21 January 2018

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Raising the NKT cell family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Distinct functional lineages of human V(alpha)24 natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Differential antitumor immunity mediated by NKT cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Phenotypic and functional differences between NKT cells colonizing splanchnic and peripheral lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Regulatory T cells under scrutiny

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Natural killer T cells: natural or unnatural regulators of autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Multiple immuno-regulatory defects in type-1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Presumed guilty: natural killer T cell defects and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Testing the NKT cell hypothesis of human IDDM pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Frequency and function of circulating invariant NKT cells in autoimmune diabetes mellitus and thyroid diseases in Colombian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Mechanism of regulation of autoimmunity by iNKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Immune cell crosstalk in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Clinical application of NKT cell biology in type I (autoimmune) diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

NKT-cell-based immunotherapies in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Lipid and glycolipid antigens of CD1d-restricted natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Immune intervention in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

C-peptide an adequate endpoint in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Phenotypic and genetic analyses of T-cell-mediated immunoregulation in patients with Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0199-0

Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells

21 January 2018

1 reference

12 December 2020

NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes

1 reference

12 December 2020

Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells

1 reference

12 December 2020

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors

1 reference

12 December 2020

Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells

1 reference

12 December 2020

NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen

1 reference

12 December 2020

NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells

1 reference

12 December 2020

Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood: implications for human studies

1 reference

12 December 2020

Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts

1 reference

12 December 2020

Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice

1 reference

12 December 2020

High frequency of valpha24(+) vbeta11(+) T-cells observed in type 1 diabetes

1 reference

12 December 2020

Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells

1 reference

12 December 2020

Repeated -Galactosylceramide Administration Results in Expansion of NK T Cells and Alleviates Inflammatory Dermatitis in MRL-lpr/lpr Mice

1 reference

12 December 2020

Immunoregulatory Role of CD1d in the Hydrocarbon Oil-Induced Model of Lupus Nephritis

1 reference

12 December 2020

Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse

1 reference

12 December 2020

Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11

1 reference

12 December 2020

Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15

1 reference

12 December 2020

The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors

1 reference

12 December 2020

Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency

1 reference

12 December 2020

Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes

1 reference

12 December 2020

Immune regulatory T cells in siblings of children suffering from type 1 diabetes mellitus

1 reference

12 December 2020

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

1 reference

12 December 2020

Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator

1 reference

12 December 2020

CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope

1 reference

12 December 2020

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

1 reference

12 December 2020

10.1007/S10238-012-0199-0

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1002335254

0 references

1 reference